#fda

#fda

Organic eggs sold at Costco are recalled due to Salmonella concerns, affecting five states, but no illnesses have been reported yet.

Eggs recalled from Milo's Poultry Farms pose serious health risks due to potential salmonella contamination.

Kirkland organic eggs sold at Costco have been recalled due to potential Salmonella contamination.

Salmonella and Listeria contamination prompts voluntary withdrawal of specific dog food products by Answers Pet Food.

The Supreme Court will review the FDA's decision to block flavored e-cigarettes aimed at reducing youth vaping rates.

The Supreme Court's upcoming decision could impact the market for flavored e-cigarettes and nicotine products.

Continued legal challenges highlight the tensions between youth smoking prevention and adult smoking cessation efforts.

The Supreme Court will hear arguments regarding the FDA's ban on flavored reusable e-cigarettes, which was aimed at decreasing teen vaping.

Teen vaping rates have significantly declined due to aggressive FDA restrictions on flavored e-cigarettes.

FDA recalls vegetables due to E. coli contamination concerns involving multiple brands and major retailers.

Costco recalled butter products due to missing milk allergen information on labels, potentially jeopardizing consumer health.

The recent Lactaid milk recall underscores the importance of food safety for individuals with allergies.

Costco's butter recall highlights the importance of allergen labeling for consumer safety.

The FDA's Class II classification indicates serious but typically reversible health risks for consumers with milk allergies.

Trump's proposed dismantling of public health agencies may encounter significant resistance from civil servants committed to scientific integrity and public safety.

The U.S. food supply remains one of the world's safest despite numerous recalls and outbreaks.

U.S. households can order four additional COVID-19 test kits for free starting September 2024.

Check the FDA website to verify if your expired tests are still usable.

FDA proposes removing phenylephrine from over-the-counter cold medicines due to its ineffectiveness.

FDA proposes to remove oral phenylephrine from OTC drugs due to its ineffectiveness as a decongestant.

Kennedy's potential influence on public health oversight could undermine health regulations and increase preventable diseases.

Trump's health appointments aim to reshape public health priorities amid controversy.

Trump nominated Dr. Martin A. Makary as FDA commissioner to restore public trust and prioritize safety in food and drug regulations.

RFK Jr. could control health policies in a Trump administration, alarming Democrats.

Kamala Harris opposed RFK Jr.'s influence on health policy.

Kennedy criticized the FDA for suppressing health alternatives.

Ted Kennedy Jr. voiced concerns over RFK Jr.'s lack of medical understanding.

Male birth control options are nearing market readiness amid political uncertainty surrounding women's health and drug approvals.

Robert F. Kennedy Jr. calls for a significant overhaul of the FDA due to concerns over food safety and children's health.

E. coli outbreak linked to McDonald's onions has affected 90 individuals across 13 states, prompting recalls and investigations.

Stephanie Petersen uses TikTok to raise awareness about food recalls and safety.

High levels of lead found in applesauce targeted at children have caused recalls and raised serious health concerns.

Bimbo Bakeries defies FDA warnings on sesame labeling, asserting it's safer for allergic consumers despite misleading claims. Accuracy in food labeling is crucial.

Rizo-López Foods has ceased production due to a listeria outbreak that resulted in multiple illnesses and fatalities.

The FDA is considering removing Wegovy from its shortage list, which impacts compounded versions being provided to patients.

Compounded drugs are filling the gap for many patients who can't afford or find Wegovy, highlighting their role in treatment options.

FDA warns about safety issues with compounded weight-loss drugs as pharmaceutical companies fight against them amid legal battles and differing interests.

The FDA has resolved the tirzepatide shortage, improving access to brand-name drugs but disrupting the compounded medication market.

Trump's potential second term threatens to reshape healthcare policy in California, impacting various health rights and regulations.

Trump nominated former Fox contributors Dr. Janette Nesheiwat and Dr. Marty Makary to significant health administration roles, emphasizing preventive care and trust restoration.

Endo expanded its clonazepam recall due to mislabeling, heightening safety concerns for patients.

Dynarex expands recall of baby powder for potential asbestos contamination affecting products in 35 states.

The FDA has authorized a clinical trial on marijuana's effectiveness for PTSD, marking a significant policy shift towards recognizing its therapeutic uses.

The FDA's rejection of MDMA-AT marks another setback in PTSD treatment options, with no new drugs approved in 24 years.

The FDA has delayed the approval of MDMA-assisted therapy for PTSD, raising concerns but also prompting further research by the VA to validate its efficacy.

MDMA-assisted psychotherapy is a promising treatment for PTSD and complex trauma, showing high efficacy and low dropout rates.

Tom's of Maine toothpaste was made with bacteria-contaminated water, risking consumer health despite their commitment to natural ingredients.

Tom's of Maine toothpaste was manufactured using contaminated water, posing health risks to consumers.

The company has a history of ignoring bacterial contamination and consumer complaints.

The FDA is proposing to revoke the effectiveness status for certain phenylephrine ingredients in OTC medications, citing a lack of efficacy.

FDA proposes to remove oral phenylephrine from over-the-counter medications due to its ineffectiveness as a nasal decongestant.

Ultraprocessed foods' dominance in the American diet contributes significantly to chronic health issues and the acceptance of disease as normal.

Josh Brolin frequently uses nicotine pouches, even while asleep, highlighting potential addiction issues.

Trump's backing of Kennedy suggests radical changes in health policy if elected.

Kennedy aims to overhaul the FDA, criticizing its ties to the pharmaceutical industry and asserting a new direction in public health regulation.

Trump endorses Robert F. Kennedy Jr. for a health position, indicating potential major reforms.

Kennedy's radical approach to health policy raises eyebrows amid his conspiracy theorist background.

Hatch-Waxman Act enables patent term extensions to counteract premarket regulatory delays.

The Federal Circuit's decision in Teva v. Amneal could redefine pharmaceutical patent listing requirements under the Hatch-Waxman Act.

The ruling may impact how device patents related to drugs are treated in the FDA's Orange Book.

Pivotal Peptides is allegedly operating in a way that poses significant risks to patient safety, utilizing coded language for product orders.

Concerns over potential conflicts of interest regarding FDA's Dr. Jeffrey Shuren's role and his wife's position in medical device law.

Dr. Michelle Tarver begins her new role at the FDA to strengthen safety standards and restore credibility regarding medical device regulation.

Thalidomide caused more harm in the U.S. than previously recognized, with Jennifer Vanderbes discovering at least ten times more victims.

Frances Oldham Kelsey is hailed as a hero for preventing thalidomide's approval in the U.S., saving countless lives from its severe side effects.

The FDA's decision to change a prior ruling alleviated patient access issues but raised safety concerns regarding compounded drugs.

Hims & Hers stock dropped nearly 10% due to FDA lifting drug shortages for competitor Eli Lilly, while its own semaglutide product remains unaffected.

Eli Lilly's medications are no longer in shortage, affecting the market for knockoff versions.

The FDA has resolved the shortage of Zepbound and Mounjaro, impacting compounded alternatives.

Blindsight implant receives breakthrough designation for its potential to restore vision in blind individuals.

Neuralink's Blindsight has FDA breakthrough status, but it's premature to claim it can cure blindness.

Neuralink's Blindsight aims to restore vision for individuals with severe visual impairments, including those with damaged optic nerves.